Michael Davidson to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Michael Davidson has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
0.270
-
Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of Anticancer Treatment-Induced Cardiotoxicity in Non-Small-Cell Lung Cancer: A Real-World Study. Clin Lung Cancer. 2024 01; 25(1):e35-e42.
Score: 0.108
-
Up-front cell-free DNA next generation sequencing improves target identification in UK first line advanced non-small cell lung cancer (NSCLC) patients. Eur J Cancer. 2022 08; 171:44-54.
Score: 0.099
-
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemother Pharmacol. 2016 Feb; 77(2):375-83.
Score: 0.063